In this study, we observed that pediatric patients with acute myeloid leukemia (AML) exhibiting co-expression of NUP98-NSD1, FLT3-ITD, and WT1 in our cohort showed a lower response rate to chemotherapy. Here, FLT3 is linked to acute myeloid leukemia.